(Date:11/23/2009)...Call/--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),...developingandcommercializingsignificantproductspri...uncedthatCraigA.Collard,PresidentandChiefExecutive...tAnnualPiperJaffrayHealthCareConferenceat3:30PMETo...NewYorkCity. ,, AliveaudioandarchivedwebcastofC...
(Date:11/20/2009)...FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ...nistration (FDA) provided written acknowledgement ...cation (BLA) for PROVENGE® (sipuleucel-T) is ...ription Drug User Fee Act (PDUFA) date of May 1, 2...mended BLA. Dendreon is seeking licensure for PRO...
(Date:11/20/2009)...recently announced that a free webinar, “Rol... Particle Characterization”, will be present...ication of in situ particle characterization is de...series of roller compaction runs while varying raw...es. , (PRWEB) November 20...
(Date:11/19/2009)...irstCall/ -- Omeros Corporation (Nasdaq: OMER ) t... third quarter ended September 30, 2009. For the t...ted a net loss of $3.9 million, or $1.34 per share....54 per share, for the same period in 2008. For th...y reported a net loss of $15.5 million, or $5.29 p...
Breaking Biology Technology:Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8...Madison, Wis. - CDW Corp. , a $6 billion-a-year ...er based in Vernon Hills, Ill., has agreed to acqu... Networks Corp. for $175 million in cash. , ,The...s of both companies, is expected to close by the e... approval by Berbee shareholders. , ,Berbee, which...
...Madison, Wis. - Not everyone is a fan of providin...e most up-to-date technology - fiber to the premis...,t continue to lead the pack with trailing-edge te...small and mid-sized businesses have a different ca...edicated Internet, a DSL product that provides bus...
...Madison, Wis. - The Madison-based National Stem ...ryonic stem cells from the University of Californ...l lines available on the federal registry. , ,Beth...h Institute , which houses the stem cell bank, sai...y will have all 21 federally approved lines. , ,"W...
Other Biology Technology:Berbee believes acquisition by CDW will make it a national IT player 2Berbee believes acquisition by CDW will make it a national IT player 3TDS believes faster DSL service will suit small businesses 2Nation's only stem cell bank will receive UC-San Francisco cell line 2Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Normal Human Serum from 3H Biomedical AB
...eacon Designer designs oligos for SYBR Green, TaqM...n, NASBA and FRET assays. Highly specific primers ... automatically interpreting BLAST search results. ... secondary structures identified by connecting to ...
Biology Products: